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PStress Imaging
omparison of Treadmill Exercise
ersus Dipyridamole Stress With
yocardial Perfusion Imaging Using
ubidium-82 Positron Emission Tomography
enjamin J. W. Chow, MD, FACC, Karthikeyan Ananthasubramaniam, MD, FACC,
obert A. deKemp, PHD, Mary M. Dalipaj, MRT(N), Rob S. B. Beanlands, MD, FACC,
errence D. Ruddy, MD, FACC
ttawa, Ontario, Canada
OBJECTIVES This study assessed the feasibility of treadmill exercise rubidium-82 (82Rb) positron emission
tomography (PET) and compared image quality and diagnostic content with dipyridamole
82Rb PET in patients referred for evaluation of coronary artery disease (CAD).
BACKGROUND Dipyridamole stress 82Rb PET myocardial perfusion imaging (MPI) is an accurate imaging
modality used to diagnose CAD and determine prognosis. Although pharmacologic stress is
used routinely, exercise treadmill stress may be an alternative and provide clinical information
helpful to decision making, particularly for patients unwilling or unable to tolerate pharma-
cologic stress.
METHODS Fifty patients (mean age, 60  10 years; 47 men) underwent treadmill exercise and
dipyridamole 82Rb PET. Images were assessed: 1) qualitatively using a 17-segment model
and a semiquantitative visual score on a five-point scale and with calculation of summed stress
score (SSS), summed rest score (SRS), and summed difference score (SDS); and 2)
quantitatively with a 70% threshold for abnormal perfusion and expressed as extent of
abnormal perfusion (% left ventricular).
RESULTS Treadmill exercise was preferred by 74% of patients (37 of 50, p  0.001). The exercise and
dipyridamole 82Rb PET summed scores and quantitative extent of abnormal perfusion were
very similar and highly correlated. Results of Bland-Altman analysis showed no significant
bias. Image quality was superior with exercise stress with greater myocardial uptake and
higher target to background ratios.
CONCLUSIONS Treadmill exercise 82Rb PET is feasible and provides imaging results of similar diagnostic
content and superior image quality compared with dipyridamole stress. Treadmill exercise
is a reasonable alternative to pharmacologic stress with 82Rb PET MPI. (J Am Coll
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.01.016Cardiol 2005;45:1227–34) © 2005 by the American College of Cardiology Foundation
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iipyridamole stress positron emission tomographic (PET)
yocardial perfusion imaging (MPI) is a highly sensitive
nd specific noninvasive modality for detection of coronary
rtery disease (CAD) (1–6). The superior diagnostic accu-
acy of PET relative to conventional gamma camera imag-
ng is largely attributable to accurate attenuation correction
nd greater camera sensitivity.
Exercise is a safe physiologic stress, and exercise testing
ermits correlation of symptoms with exertion, measure-
ent of exercise capacity and functional status, and assess-
ent of efficacy of medical therapy. Experience with exer-
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004; accepted January 4, 2005.ise testing with PET has been limited. Supine bicycle
rgometry has been used successfully with rubidium-82
82Rb) PET (7) but has not been adopted into clinical
ractice. Treadmill exercise results in a greater exercise
orkload than bicycle stress and is used more widely in
orth America. Patients unwilling or unable to tolerate
harmacologic stress may be candidates for exercise stress.
Although 13N-ammonia and 15O-H2O are available for
ET MPI, clinical availability has been limited by the need
or on-site cyclotrons. Rubidium-82, a generator-produced
adioisotope, is commonly used for MPI. The short half-life
f 82Rb (76 s) minimizes the time required for rest and
tress imaging but has made its use with treadmill exercise
tress logistically difficult.
To our knowledge, 82Rb PET MPI has never been
ombined with exercise treadmill stress testing. The objec-
ive of this study was to determine the feasibility of 82Rb
ET MPI with treadmill exercise stress and to compare
mage quality and diagnostic content with dipyridamole
ET MPI.
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tudy population and design. Between November 2001
nd March 2003, 53 patients were prospectively enrolled
nto this single-center single-blinded study for comparison
f exercise versus dipyridamole stress PET MPI. A second
roup of 15 patients underwent two serial rest and dipyrid-
mole stress PET MPI studies for determination of the
epeatability of dipyridamole stress PET MPI for compar-
son with the observed differences of exercise versus dipy-
idamole stress PET MPI. The total study population
ncluded 68 patients. All patients had either documented
AD or an intermediate (20% to 80%) to high pre-test
robability (80%) for CAD using Diamond and Forrester
riteria (8). All patients were referred for dipyridamole PET
PI for diagnosis of CAD or to determine prognosis.
xclusion criteria included inability to give informed con-
ent; age 18 years; inability to exercise on a treadmill;
ontraindication to dipyridamole such as asthma, broncho-
pasm, or theophylline dependence; or contraindication to
adiation exposure such as pregnancy or breastfeeding,
ngoing enrollment in other research involving radiation, or
ccupational radiation exposure. All patients gave informed
onsent to participate in the study. The study protocol was
pproved by the University of Ottawa Heart Institute
uman Research Ethics Board.
Each patient underwent rest and dipyridamole stress
ETMPI on one day and rest and exercise stress PETMPI
n a different day. Patients abstained from caffeine, xanthine
erivatives, and atrioventricular (AV) nodal blocking drugs
or 12 h or longer and remained fasting except for medica-
ions for 6 h or longer before each study. Patients with
hanges in anginal pattern or cardiac medications between
he dipyridamole and exercise PET MPI studies were
xcluded. The order of dipyridamole versus exercise stress
as determined by availability of resources. Upon comple-
ion of both dipyridamole and treadmill exercise, PET
atients were questioned regarding their preferred modality
f stress using the question: “If you had to have one of the
wo tests repeated (exercise or drug stress PET) which
Abbreviations and Acronyms
APMHR  age-predicted maximum heart rate
AV  atrioventricular
CAD  coronary artery disease
CCS  Canadian Cardiovascular Society
ECG  electrocardiography
LV  left ventricular
MPI  myocardial perfusion imaging
PET  positron emission tomography
82Rb  rubidium-82
SDS  summed difference score
SRS  summed rest score
SSS  summed stress scoreould you prefer?” eET imaging. Positron emission tomography MPI imag-
ng was carried out at rest and with dipyridamole stress on
ne day and then repeated at rest and with exercise stress on
different day. The PET images were acquired with an
CAT ART whole body scanner (Siemens/CTI, Knoxville,
ennessee) equipped with 24 detector rings allowing the
cquisition of 47 contiguous transaxial slices. The same
maging protocol was used for rest and stress imaging. A
our-min cesium-137 transmission scan was acquired to
onfirm proper patient positioning and for attenuation
orrection (9). Chest markings with dye and the field of view
ositioning lasers of the PET camera ensured accurate re-
ositioning of patients. After acquisition of transmission data,
0 to 35 mCi (370 to 1,295 MBq) of 82Rb was infused over
0 s at rest (or with stress as described in the subsequent
ext) and followed by a saline flush over 1 min using a
ustom infusion system. A 10-min dynamic acquisition was
btained, and static uptake images were created by summing
he last 7.5 min of dynamic data. After rest imaging, an
dditional 10 min was allowed for decay of the 82Rb
etween rest and stress imaging. A post-test 4-min trans-
ission scan was acquired for attenuation correction after
he stress exercise and dipyridamole scans. All images were
econstructed using filtered backprojection with a Hann
indow cut-off of 18 mm and using scatter and attenuation
orrection.
ipyridamole stress testing. Dipyridamole (0.14 mg/kg/
in) was infused over five min. Heart rate and blood
ressure were measured every three min, and electrocardi-
graphy (ECG) was monitored continuously. Eight min
fter initiation of dipyridamole infusion, 82Rb was admin-
stered. Image acquisition began with the onset of 82Rb
nfusion. A 10-min dynamic acquisition was obtained, and
tatic uptake images were created by summing the last 7.5
in of dynamic data. Aminophylline (2 mg/kg) was infused
2 min after initiation of dipyridamole infusion.
xercise stress testing. The Bruce protocol was used for
he treadmill exercise protocol. Age-predicted maximal
eart rate (APMHR) was estimated by 220  age (10).
eart rate and blood pressure were measured every three
in, and ECG was monitored continuously. During the last
.5 min of peak exercise the patient received 82Rb intrave-
ously. Upon completion of the treadmill exercise, the
atient was repositioned in the PET scanner approximately
hree min after the onset of 82Rb infusion. A 7.5-min
ummed static uptake PET image was acquired.
CG and image analysis. Positive ST-segment depression
as defined as1mmhorizontal or downsloping ST-segment
epression at the J point persisting 80 ms beyond the J point or
1.5 mm upsloping depression at 80 ms beyond the J point
11). In patients with heart rates 135 beats/min, ST-
egment measurements were performed 60 ms beyond the J
oint (11).
The PET images were assessed qualitatively by twoxpert observers blinded to the modality of stress and using
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April 19, 2005:1227–34 Exercise Versus Dipyridamole 82Rb PET17-segment model and a five-point grading system (0 
ormal radiotracer uptake, 1  mildly reduced, 2 
oderately reduced, 3  severely reduced, and 4  absence
f radiotracer uptake) (12). Summed stress score (SSS),
ummed rest score (SRS), and summed difference score
SDS) were calculated. Images were also analyzed quanti-
atively by a sectored analysis approach for rest and stress
efect size using a 70% threshold cut-off for abnormal
erfusion (13).
Image quality was assessed with criteria based on myo-
ardial count density (Bq/cc) and target: background ratios
myocardium/lung, myocardium/gut, myocardium/liver,
nd myocardium/ blood pool) (14–16). Using transaxial
lices of the myocardium, regions of interest for each patient
ere positioned using the same locations: myocardium as
able 1. Dipyridamole and Exercise Treadmill Stress Clinical
nd ECG Data
Dipyridamole Exercise p Value
est HR (beats/min) 59  10 64  9 NS
est systolic BP
(mm Hg)
144  27 139  19 NS
est diastolic BP
(mm Hg)
76  12 77  9 NS
est HR-BP product 8,982  2,433 8,895  1,819 NS
eak HR (beats/min) 79  16 145  20 0.001
eak systolic BP
(mm Hg)
139  22 182  26 0.001
eak diastolic BP
(mm Hg)
74  11 87  11 0.001
eak HR  pressure 11,087  3,462 26,519  5,372 0.001
atients with STD 14 (28%) 31 (62%) 0.001
eads with STD 1.1  1.9 2.2  2.2 0.001
aximum STD (mm) 0.5  1.0 1.3  1.4 0.001
atients with ST-
segment elevation
1 4 NS
atients with chest pain 31 (62%) 19 (38%) 0.002
atient stress preference 13 (26%) 37 (74%) 0.001
P blood pressure; ECG electrocardiographic; HR heart rate; HR pressure
rate-pressure product; STD  ST-segment depression.
Table 2. Dipyridamole and Exercise Treadmill
Dipyrid
Rest 82Rb dose (MBq) 786 
Stress 82Rb dose (MBq) 789 
SRS 2.2 
SSS 7.2 
SDS 5.0 
Rest defect (% LV) 4.6 
Stress defect (% LV) 15.2 
Rest myocardial uptake (Bq/cc) 11,293 
Stress myocardial uptake (Bq/cc) 14,476 
Myocardium/lung rest 10.9 
Myocardium/lung stress 12.3 
Myocardium/gut rest 1.2 
Myocardium/gut stress 1.8 
Myocardium/liver rest 3.8 
Myocardium/liver stress 3.4 
Myocardium/blood pool rest 2.5 
Myocardium/blood pool stress 3.0 LV  left ventricle; SDS  summed difference score; SRS  sumyocardial region with the highest counts, lung as a 31 
3-voxel triangular area in the left lung, gut as a 6 6-voxel
rea over the gut activity closest to the myocardium, liver as
11 16-voxel area in the right upper lobe of the liver, and
lood pool as a circular region with a diameter of 10 voxels
n the center of the left ventricular (LV) cavity.
tatistical analysis. Statistical analysis was done using
PSS version 11.5 (Chicago, Illinois). Paired continuous
ariables were evaluated using the t test, and noncontinuous
ariables with chi-square testing. The concordance of the
bserver grading of the exercise and dipyridamole stress
cans was evaluated by calculating Kappa scores. Perfusion
efects estimated as summed scores and %LV defect from
he exercise and dipyridamole stress studies were correlated
sing a Pearson correlation coefficient and Bland-Altman
lot analyses (17). Repeatability of the exercise and dipy-
idamole stress studies was calculated using the repeatability
oefficient (17) and compared with repeatability of two
ipyridamole stress studies. The repeatability coefficient is
wice the standard deviation of the differences between the
nitial and repeated tests (17).
ESULTS
atient population. We prospectively enrolled 53 patients
ho underwent both treadmill exercise and dipyridamole
tress 82Rb PET. One patient was excluded for premature
ermination of exercise (before 82Rb infusion). Two patients
ere excluded for significant changes in symptoms of angina
etween the two studies. One patient had worsening angina
lass (Canadian Cardiovascular Society [CCS] class 2 to 3).
ne patient had improvement in angina class (CCS class
to 1). The remaining 50 patients (mean age 60 10 years;
7 men) completed the study and underwent both treadmill
xercise and dipyridamole stress 82Rb PET. Thirty-seven
74%) patients had documented history of CAD (27 pa-
ients had a history of myocardial infarction, 29 had
ss Image Data
le Exercise p Value
770  171 NS
757  188 NS
2.1  4.1 NS
6.6  7.7 NS
4.5  5.3 NS
4.3  7.9 NS
2 14.4  16.0 NS
68 12,192  4,597 NS
29 22,405  10,747 0.001
12.4  14.5 NS
14.8  9.3 NS
1.1  0.4 NS
5.1  4.0 0.0001
2.8  0.9 NS
26.9  66.8 0.02
2.5  0.8 NS
3.8  1.1 0.001Stre
amo
206
185
3.7
8.3
6.0
7.6
16.
3,6
4,0
4.8
4.4
0.7
1.5
3.6
1.4
0.8
0.8med rest score; SSS  summed stress score.
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Exercise Versus Dipyridamole 82Rb PET April 19, 2005:1227–34revious revascularization with 27 having percutaneous
oronary interventions and 9 having coronary artery bypass
urgery). The remaining 13 (26%) patients had either
ntermediate or high pre-test probability for CAD. Cardiac
isk factors included hypertension in 27 (54%), diabetes in
0 (20%), current smoking in 9 (18%), previous smoking in
0 (60%), family history of CAD in 17 (34%), and dyslip-
demia in 39 (78%) patients. The second set of 15 patients
mean age 64  14 years; 13 men) undergoing two serial
igure 1. Summed scores for dipyridamole and exercise treadmill stress
mages: (A) summed stress score; (B) summed rest score; (C) summed
ifference score.est and dipyridamole stress PET MPI studies for determi- wation of the repeatability of dipyridamole stress PET MPI
ere similar to the 50 patients undergoing exercise and
ipyridamole stress PET MPI.
tress testing. The median time interval between treadmill
xercise and dipyridamole stress studies was 6 days with a
ean of 13  26 days. Patients exercised an average of 8.4
2.4 min. The mean % APMHR was 88  11% with 37
74%) patients achieving 85% APMHR. For exercise
tress studies, mean time interval from onset of 82Rb
nfusion to initiation of acquisition of emission data was 3.0
0.5 min.
Exercise and dipyridamole stress test results are compared
n Table 1. Peak heart rate, blood pressure, and rate-
ressure product were significantly greater with exercise
han dipyridamole stress. ST-segment depression was more
ommon and in more leads with treadmill exercise than
ipyridamole stress. Conversely, chest pain was more fre-
uent with dipyridamole versus treadmill exercise stress.
ore patients preferred treadmill exercise over dipyridam-
le stress. Of the 13 patients with submaximal exercise
tress, 6 discontinued exertion due to chest pain, 5 due to
atigue, and 2 due to dyspnea.
PI. The SSS, SRS, SDS, and quantitative defect sizes
igure 2. Quantitative perfusion defect size (% left ventricle) for dipyrid-
mole and exercise treadmill stress images: (A) summed stress score; (B)
ummed rest score.ith dipyridamole versus exercise stress 82Rb PET MPI
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April 19, 2005:1227–34 Exercise Versus Dipyridamole 82Rb PETere very similar (Table 2) and highly correlated (Figs. 1
nd 2). One patient had a significant discrepancy between
xercise SSS (0.75) and dipyridamole SSS (12.5). During
xercise, this patient had a significant drop in systolic blood
ressure of 30 mm Hg, which may have resulted in global
yocardial hypoperfusion and less marked heterogeneity in
yocardial perfusion (Figs. 3 and 4).
Bland-Altman analysis (Fig. 5, Table 3) for the SSS,
RS, SDS and quantitative defect sizes (dipyridamole vs.
xercise stress 82Rb PETMPI) showed no significant bias with
he mean of the differences similar to zero and no systematic
verestimation or underestimation. In addition, agreement
etween dipyridamole versus exercise stress 82Rb PET MPI
as similar to the agreement observed between repeated
ipyridamole stress 82Rb PET MPI studies (Table 3).
epeatability coefficients for dipyridamole versus exercise
tress 82Rb PET MPI data were similar to results with
epeated dipyridamole stress 82Rb PETMPI studies (Table 3).
igure 3. Discordant exercise (A) and dipyridamole (B) rubidium-82
ositron emission tomography images. During exercise, systolic blood
ressure decreased by 30 mm Hg. The area of ischemia is much smaller on
he exercise study compared with that on the dipyridamole study. However,
he exercise study also shows transient dilation of the left ventricle
onsistent with significant ischemia. HLA  horizontal long axis; SA 
hort axis; VLA  vertical long axis.appa scores assessing concordance for categories of nor- wal/equivocal versus abnormal for the exercise versus dipy-
idamole SSS and SRS were good to very good on a patient
evel (0.72 and 0.85, respectively; Table 4) and by coronary
rtery territories (left anterior descending 0.72 and 0.58 , left
ircumflex 0.72 and 0.78, right coronary 0.71 and 0.75,
espectively).
Because some of the variability between dipyridamole
ersus exercise stress may be related to submaximal exercise
tress, an analysis of SSS and stress defect (% LV) was
erformed in patients (n  13) with submaximal exercise
tress (heart rate85% APMHR). The SSS (5.8 5.5, 5.1
5.9, respectively; p  NS) and quantitative defect sizes
14.1  15.0, 13.9  17.0, respectively; p  NS) with
ipyridamole versus exercise stress were very similar and
ighly correlated (r  0.96, p  0.001 and r  0.96, p 
.001, respectively).
Myocardial 82Rb uptake was significantly greater with
xercise compared with dipyridamole stress (Table 2).
igher ratios of myocardial uptake to gut, liver, and blood
ool uptake were observed with exercise stress compared
igure 4. Concordant exercise (A) and dipyridamole (B) rubidium-82
ositron emission tomography images. Both exercise and dipyridamole
tudies show inferolateral ischemia of similar degree. HLA  horizontal
ong axis; SA  short axis; VLA  vertical long axis.ith dipyridamole stress (Table 2).
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his study demonstrates that treadmill exercise 82Rb PET
PI is feasible. The diagnostic content of the images and
epeatability is very similar to dipyridamole 82Rb PETMPI.
n addition, the image quality associated with treadmill
xercise is better than with dipyridamole stress.
Exercise treadmill stress has proven to be safe in all ages
18) and yields additional information unobtainable with
harmacologic stress. Exercise treadmill stress quantifies
xercise capacity and functional status, correlates symptoms
ith exertion, assesses the effectiveness of medical therapy,
nd may provide prognostic information (19). In this study,
igure 5. Bland-Altman plots (difference vs. mean) of summed scores for
ipyridamole and exercise treadmill stress images: (A) summed stress score;
B) summed rest score; (C) summed difference score.atients preferred treadmill exercise to dipyridamole stress. rPrevious studies have found similar sensitivity (60% to
4% vs. 48% to 100%) and specificity (68% to 100% vs. 64%
o 100%) of exercise and dipyridamole thallium-201 and
echnetium-99m single photon emission computed tomog-
aphy in detecting significant coronary stenoses (20,21).
owever, one study found that dipyridamole thallium-201
ay be more sensitive than exercise thallium-201 (70% vs.
2%) in detecting coronary stenoses between 40% and 60%
21). Similar diagnostic results with myocardial perfusion
maging after dipyridamole and exercise stress suggest that
adiotracer uptake is also similar. However, changes in
oronary blood flow induced by exercise and dipyridamole
iffer with increases in normal coronary arteries by exercise
f 100% to 300% and dipyridamole of 400% (22). In
ddition, impaired vasodilation with dipyridamole has been
hown (23) and may partially explain the greater myocardial
ptake of 82Rb after exercise observed in this study.
Supine bicycle exercise PET has been performed success-
ully (7,24,25) and permits dynamic data acquisition with
ome potential patient motion during emission data acqui-
ition. Although exercise stress PET has not been adopted
nto common practice in North America, exercise treadmill
tress is commonly used and readily available. Dynamic data
cquisition is not possible with treadmill exercise stress, and
readmill exercise has not been performed previously with
2Rb PET. Camici et al. (7) found that areas of reduced
2Rb uptake returned to control values after 5 to 14 min
fter the end of bicycle exercise, which may limit the time
vailable for emission acquisition. In our study, 3.0 min
ere required for 82Rb infusion, saline flush, termination of
readmill exercise, and repositioning in the PET camera.
mage acquisition required an additional 7.5 min. Thus, a
otal of 10.5 min was required for image acquisition with the
readmill 82Rb PET MPI protocol.
Variability between treadmill exercise and dipyridamole
tress defect size studies may be explained partially by the
ariability of the time intervals from 82Rb infusion and
eginning of image acquisition. The larger stress defect sizes
bserved in some patients with exercise may have been
elated to submaximal vasodilation with dipyridamole or
llicit ingestion of caffeine. Although submaximal exercise
tress may lead to an underestimation of the extent of
schemia, similar SSS and quantitative defect sizes were
bserved in the subgroup analysis of patients with submaxi-
al exercise.
Repeatability of exercise 82Rb PET MPI was not evalu-
ted specifically. However, the differences between exercise
nd dipyridamole 82Rb PET MPI were compared with the
epeatability of dipyridamole 82Rb PET MPI and found to
e very similar.
The image quality with treadmill exercise was superior to
ipyridamole stress images with higher ratios of myocardial
ptake to gut and liver uptake after exercise stress and was
ossibly related to increased sympathetic tone and reduction
f splanchnic blood flow as previously reported with dipy-
idamole thallium imaging (15). The higher ratio of myo-
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April 19, 2005:1227–34 Exercise Versus Dipyridamole 82Rb PETardial uptake to blood pool uptake after exercise stress may
e related to the 30-s delay in acquisition of the exercise
mages and more time for blood pool clearance.
Our clinical experience with treadmill exercise stress 82Rb
ET was very positive but did present technical challenges.
fter treadmill exercise stress, extra care had to be taken
ith repositioning the patient in the PET scanner to ensure
hat the patient’s heart was within the field of view of the
ET camera. The chest of each patient was marked with blue
ye, and patients were repositioned after exercise by aligning
he chest markings with the laser system of the camera. The
readmill had to be adjacent to the PET camera to expedite
mmediate imaging and ECG monitoring. In addition, differ-
nces in breathing between the emission and transmission
mages may lead to errors in registration of the images and alter
erfusion particularly in the inferior wall. However, careful
eview of patient images did not identify any patients with
pparent misregistration, and there were no statistically
ignificant differences in perfusion defects in the inferior
all between dipyridamole and exercise stress.
Rubidium-82 is a radiotracer that can be used in centers
ithout immediate access to a cyclotron. The short half-life
f 82Rb has both benefits and detriments when used in
PI. The very short half-life reduces overall test duration.
owever, its short half-life also limits the time available for
mission image acquisition and requires rapid patient trans-
er from the treadmill to the PET camera. 13N-ammonia
as several benefits over 82Rb and may be an ideal radio-
racer to be used in conjunction with treadmill exercise
ET. 13N-ammonia’s longer half-life (10 min) would elim-
nate the time constraints encountered with 82Rb. As a
olus infusion, it would reduce infusion time and allow its
able 4. Concordance of Normal and Abnormal Studies for
xercise Versus Dipyridamole Stress Studies
Dipyridamole
Normal Abnormal Total
Exercise Summed Stress Scores*
ormal 20 5 25
bnormal 2 23 25
otal 22 28 50
Summed Rest Scores†
ormal 41 0 41
bnormal 2 7 9
otal 43 7 50
able 3. Bland-Altman and Repeatability Analysis of Summed S
Bland-Altman Analysis
Exercise-Dipyridamole Dipyridamole-D
RS 0.11  1.43 0.20 
SS 0.59  3.95 0.20 
est defect (% LV) 0.26  3.83 0.06 
tress defect (% LV) 0.79  9.64 0.66 
V  left ventricle; SRS  summed rest score; SSS  summed stress score.Kappa  0.72; †Kappa  0.85.nfusion to be temporally closer to peak exercise. In addi-
ion, 13N-ammonia has lower positron energy than 82Rb
nd may result in better image quality and resolution.
ONCLUSIONS
readmill exercise 82Rb PET is feasible and provides
maging results of similar diagnostic content and better
uality compared with dipyridamole stress. In our study,
readmill exercise stress was preferred over dipyridamole
tress by patients who can exercise. The option of treadmill
xercise PET can be now considered in patients requiring
valuation of CAD.
cknowledgements
he authors extend their gratitude to May Aung, Laurie
ennet, Sandina Cordani, Kim Gardner, Debbie Gauthier,
nd Lyanne Fuller for their technical assistance and expertise.
eprint requests and correspondence: Dr. Terrence D. Ruddy,
niversity of Ottawa Heart Institute, 40 Ruskin Street (H-1 PET
entre), Ottawa, ON K1Y 4W7 Canada. E-mail: truddy@
ttawaheart.ca.
EFERENCES
1. Beanlands R. Positron emission tomography in cardiovascular disease.
Can J Cardiol 1996;12:875–83.
2. Gould LK. PET perfusion imaging and nuclear cardiology. J Nucl
Med 1991;32:579–606.
3. Go RT, Marwick TH, MacIntyre WJ, et al. A prospective comparison
of rubidium-82 PET and thallium-201 SPECT myocardial perfusion
imaging utilizing a single dipyridamole stress in the diagnosis of
coronary artery disease. J Nucl Med 1990;31:1899–905.
4. Stewart RE, Schwaiger M, Molina E, et al. Comparison of
rubidium-82 positron emission tomography and thallium-201 SPECT
imaging for detection of coronary artery disease. Am J Cardiol
1991;67:1303–10.
5. Tamaki N, Yonekura Y, Senda M, et al. Value and limitation of stress
thallium-201 single photon emission computed tomography. Compar-
ison with Nitrogen-13 ammonia positron tomography. J Nucl Med
1988;29:1181–8.
6. Tamaki N, Ruddy TD, deKemp R, Beanlands RSB. Myocardial
perfusion. In: Wahl RL editor. Principles and Practice of Positron
Emission Tomography. Philadelphia, PA: Lippincott Williams &
Wilkins, 2002:320–33.
7. Camici P, Araujo LI, Spinks T, et al. Increased uptake of 18F-
fluorodeoxyglucose in postischemic myocardium of patients with
exercise-induced angina. Circulation 1986;74:81–8.
8. Diamond GA, Forrester JS. Analysis of probability as an aid in the
clinical diagnosis of coronary-artery disease. N Engl J Med 1979;300:
1350–8.
and Quantitative Defect Size
Repeatability Coefficient
damole Exercise-Dipyridamole Dipyridamole-Dipyridamole
2.84 3.74
7.90 7.61
7.59 6.96
19.15 21.05cores
ipyri
1.92
3.93
3.89
10.879. Xu EZ, Mullani NA, Gould KL, Anderson WL. A segmented
attenuation correction for PET. J Nucl Med 1991;32:161–5.
11
1
1
1
1
1
1
1
1
2
2
2
2
2
2
1234 Chow et al. JACC Vol. 45, No. 8, 2005
Exercise Versus Dipyridamole 82Rb PET April 19, 2005:1227–340. Tanka H, Monahan KD, Seals DR. Age-predicted maximal heart rate
revisited. J Am Coll Cardiol 2001;37:153–6.
1. Gibbons RJ, Balady GJ, Bricker JT, et al. American College of
Cardiology/American Heart Association Task Force on Practice
Guidelines (Committee to Update the 1997 Exercise Testing Guide-
lines). ACC/AHA guideline update for exercise testing. Circulation
2002;106:1883–92.
2. Hachamovitch R, Berman DS, Shaw LJ, et al. Incremental prognostic
value of myocardial perfusion single photon emission computed
tomography for the prediction of cardiac death. Differential stratifica-
tion for risk of cardiac death and myocardial infarction. Circulation
1998;97:535–543.
3. Hicks K, Ganti G, Millani NA, Gould KL. Automated quantitation
of 3-D cardiac positron emission tomography for routine clinical use.
J Nucl Med 1989;30:1787–97.
4. Mahmood S, Buscombe JR, Ell PJ. The use of thallium-201 lung/
heart ratios. Eur J Nucl Med 1992;19:807–14.
5. Ruddy TD, Gill JB, Finkelstein DM, et al: Myocardial uptake and
clearance of thallium-201 in normal subjects: comparison of
dipyridamole-induced hyperemia with exercise stress. J Am Coll
Cardiol 1987;10:547–56.
6. Thomas GS, Prill NV, Majmundar H, et al. Treadmill exercise during
adenosine infusion is safe, results in fewer adverse reactions, and improves
myocardial perfusion image quality. J Nucl Cardiol 2000;7:439–46.
7. Bland JM, Altman DG. Statistical methods for assessing agreement
between two methods of clinical measurement. Lancet 1986;1:307–10.8. Hashimoto A, Palmer EL, Scott JA, et al. Complications of exercise
and pharmacologic stress tests: differences in younger and elderly
patients. J Nucl Cardiol 1999;6:612–9.
9. Chaitman BR. Exercise stress testing. In: Braunwald E, Zipes DP,
Libby P, editors. Heart Disease: A Textbook of Cardiovascular
Medicine. Philadelphia, PA: W.B. Saunders Company, 2002:129–59.
0. Beer SG, Heo J, Iskandrian AS. Dipyridamole thallium imaging. Am J
Cardiol 1991;67:18D–26D.
1. Josephson MA, Brown BG, Hecht HS, Hopkins J, Pierce CD,
Petersen RB. Noninvasive detection and localization of coronary stenosis
in patients: comparison of resting dipyridamole and exercise thallium-201
myocardial perfusion imaging. Am Heart J 1982;103:1008–18.
2. Gould KL. Noninvasive assessment of coronary stenosis by myo-
cardial perfusion imaging during pharmacologic coronary vasodila-
tion. I. Physiologic basis and experimental validation. Am J Cardiol
1978;41:269–78.
3. Rossen JD, Simonetti I, Marcus ML, Winniford MD. Coronary
dilation with standard dose dipyridamole and dipyridamole combined
with handgrip. Circulation 1989;79:566–72.
4. Krivokapich J, Smith GT, Huang SC, et al. 13N ammonia myocardial
imaging at rest and with exercise in normal volunteers. Circulation
1989;80:1328–37.
5. Wyss CA, Koepfli P, Mikolajczyk K, Burger C, von Schulthess GK,
Kaufmann PA. Bicycle exercise stress in PET for assessment of
coronary flow reserve: repeatability and comparison with adenosine
stress. J Nucl Med 2003;44:146–54.
